Project Grant R34CA286602
Award Date
9/17/24
Completion Date
8/31/27
Dollars Obligated
$290K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), is focused on investigating accelerated cardiac aging in adolescent and young adult (AYA) cancer survivors. The $692,417 award will fund a 5-year research project to: Elucidate and define the prevalence of accelerated cardiac aging in a diverse cohort of 1,200 AYA cancer survivors, and Identify predictors of this accelerated cardiac aging...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $591,691 to the Regents of the University of Michigan to conduct a pragmatic randomized controlled trial evaluating the effectiveness of an intervention called CTAC (Current Together After Cancer) in improving knowledge about and self-efficacy for managing colorectal cancer surveillance, as well as improving receipt of surveillance, among 654 survivors with stages II and III...
This federal Project Grant award of $621,732 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a hybrid effectiveness-implementation trial to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The key products and services to be delivered under this 5-year grant include: 1) comprehensively assessing the...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Duke University to develop and evaluate a digital health intervention called "AYA STEPS" (Symptom Management and Transitioning to Engagement with Post-Treatment Care for Adolescent and Young Adult Cancer Survivors). The AYA STEPS intervention is designed to help the over 600,000 adolescent and young adult (AYA) cancer survivors in the U.S....
The National Cancer Institute (NCI) awarded a $1,128,600 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Utah. The grant aims to develop and evaluate a mobile health (mHealth) intervention called "Color Me Healthy" to improve symptom communication for children with cancer during the early cancer treatment period. The project will involve user-centered design to create a clinician-facing app that integrates with electronic health...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress of AYACSS through this innovative psychosocial intervention. The funded project aims to 1) develop the...
This Project Grant award of $1,533,546 from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), aims to develop and evaluate a patient-facing mobile app for comprehensive hereditary cancer risk assessment. The grant recipient, Dana-Farber Cancer Institute (DFCI), will lead an implementation science study to design, refine, and evaluate the scalability and sustainability of the PREMMPLUS app in diverse community health settings...
This federal Project Grant award, provided by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research), aims to address financial hardship among adolescent and young adult cancer survivors (AYAs) treated in community oncology practices. The $699,517 award will fund the development and testing of a multilevel intervention called "FINFIT" that combines education on health insurance literacy (CHAT) and systematic assessment of eligibility for financial support...
The National Cancer Institute (NCI) awarded a $386,866 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Regents of the University of Michigan to develop individualized estimates of treatment benefit from hormone therapy for men with prostate cancer. The project aims to integrate models for other-cause mortality risk, distant metastases, and prostate cancer-specific mortality to provide personalized estimates of treatment outcomes, and to develop a web...
This $227,941 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and pilot evaluation of the "Cancer Care Companion", an electronic health record (EHR) tool to improve communication and self-management for families of children with cancer. The project will engage parents and pediatric oncology clinicians to co-develop the Cancer Care Companion, which will leverage the existing Epic MyChart Care Companion...